A phase I study of two dosing schedules of oral BI 847325 in patients with advanced solid tumors.
Auteurs : Schöffski P, Aftimos P, Dumez H, Deleporte A, De Block K, Costermans J, Billiet M, Meeus MA, Lee C, Schnell D, Goeldner RG, Awada A
Jaar : 2016
Journal : Cancer Chemother Pharmacol
Volume : 77(1)
Pagina's : 99-108